A two-day conference bringing together senior leaders from industry, government, the NHS, and regulatory bodies to address the evolving UK HealthTech landscape. The event tackles critical challenges including regulatory strategy, market access, AI oversight, NHS adoption pathways, and system readiness for innovation at scale.
Day One (9 November 2026) focuses on regulation, covering the UK regulatory offer, recognition and reliance frameworks, early engagement with the MHRA, digital regulation, AI governance, post-market surveillance, and the role of evidence and patient trust. Keynote speakers include Lawrence Tallon, Chief Executive Officer of the MHRA, alongside regulatory leaders from major MedTech companies.
Day Two (10 November 2026) addresses market access and adoption, examining NHS access pathways, NICE frameworks, investment and commercial decision-making, local system adoption, procurement, digital transformation, and the capabilities required to scale innovation across health and care. Sessions feature speakers from NHS England, the Department of Health and Social Care, NICE, and leading healthcare innovators.
With over 200 senior participants expected each day, the conference provides direct access to policymakers, system leaders, and industry peers. It is designed for those with responsibilities in regulatory strategy, NHS adoption, investment, commercial growth, or digital health innovation.
